Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Intangibles (2016 - 2025)

Lexaria Bioscience's Intangibles history spans 11 years, with the latest figure at $308060.0 for Q4 2025.

  • For Q4 2025, Intangibles rose 2241.06% year-over-year to $308060.0; the TTM value through Nov 2025 reached $308060.0, up 2241.06%, while the annual FY2025 figure was $75106.0, 85.46% down from the prior year.
  • Intangibles for Q4 2025 was $308060.0 at Lexaria Bioscience, up from $75106.0 in the prior quarter.
  • Across five years, Intangibles topped out at $549122.0 in Q2 2023 and bottomed at $13159.0 in Q4 2024.
  • The 5-year median for Intangibles is $372543.0 (2021), against an average of $322106.6.
  • The largest annual shift saw Intangibles skyrocketed 3347.06% in 2023 before it plummeted 97.34% in 2024.
  • A 5-year view of Intangibles shows it stood at $378746.0 in 2021, then plummeted by 96.21% to $14342.0 in 2022, then surged by 3347.06% to $494377.0 in 2023, then tumbled by 97.34% to $13159.0 in 2024, then soared by 2241.06% to $308060.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Intangibles are $308060.0 (Q4 2025), $75106.0 (Q3 2025), and $60496.0 (Q2 2025).